Showing results (321-330 of 343) with videos related to
Sort By:
Pageof 35
Journal of Autoimmunity|February 1, 2024
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitisRui Wang, Qiuxiang Lin, Zhonghua Lu, et al.Journal of Autoimmunity|February 3, 2019
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?Chunyan Sun, Xiao Xiao, Li Yan, et al.JHEP Reports : Innovation in Hepatology|August 18, 2025
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapyYu Chen, Haoyu Wen, You Li, et al.Nature Communications|March 28, 2023
A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expressionYou Li, Zhiqiang Li, Ruiling Chen, et al.Clinical Reviews in Allergy & Immunology|June 9, 2026
Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score DevelopmentHaoyu Wen, Yu Chen, Qiuxiang Lin, et al.Quantitative Imaging in Medicine and Surgery|March 12, 2026
Imaging features of porto-sinusoidal vascular disorder in a case-control study: diagnostic value for differentiation from liver cirrhosisFengxiang Song, Haoxiang Zhu, Lijun Qian, et al.Alimentary Pharmacology & Therapeutics|April 1, 2022
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trialJia-Bo Wang, Ang Huang, Yijin Wang, et al.Hepatology International|January 1, 2021
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosisXin Zeng, Xia Sheng, Pei-Qin Wang, et al.Nature Genetics|April 16, 2024
A spatiotemporal atlas of cholestatic injury and repair in miceBaihua Wu, Xinyi Shentu, Haitao Nan, et al.Imeta|March 3, 2025
Gut microbiota in treating inflammatory digestive diseases: Current challenges and therapeutic opportunitiesYongpeng Shi, Zeran Chen, Tingyu Fang, et al.Pageof 35